This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Kieren Mather, MD
Associate VP-Medical-Incretins and Diabetes Breakthroughs, Early Clinical Research at Eli Lilly and Company
Speaker

Profile

Dr. Mather trained in Endocrinology in Canada. Following a 20 year academic career focused on studies of metabolic physiology and clinical trials in diabetes, he joined Eli Lilly and Company in 2020. He oversees clinical studies for the early phase portfolio of incretins and related molecules with actions in glucose and weight management.

Agenda Sessions

  • GLP-1 Clinical Progress, Pipeline and Innovation

    3:30pm